The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The use of five-alpha reductase inhibitors and their association with reclassification and pathologic outcomes in the Canary Prostate Active Surveillance Study (PASS).
 
James T Kearns
No Relationships to Disclose
 
Anna V Faino
No Relationships to Disclose
 
Lisa F Newcomb
No Relationships to Disclose
 
James D. Brooks
No Relationships to Disclose
 
Peter Carroll
No Relationships to Disclose
 
Atreya Dash
No Relationships to Disclose
 
William J Ellis
No Relationships to Disclose
 
Michael Fabrizio
No Relationships to Disclose
 
Martin Gleave
Employment - OncoGenex
Stock and Other Ownership Interests - OncoGenex
Honoraria - Astellas Pharma; Bayer; Janssen; Oncogenex
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen; Oncogenex
Research Funding - Astellas Pharma; AstraZeneca; Janssen
Patents, Royalties, Other Intellectual Property - OncoGenex - OGX-011, OGX-427
 
Todd Matthew Morgan
No Relationships to Disclose
 
Peter S Nelson
No Relationships to Disclose
 
Ian Murchie Thompson
Consulting or Advisory Role - Exosome diagnostics; Magforce
Patents, Royalties, Other Intellectual Property - I have been involved in the establishment of a new company - NanoTX Therapeutics to commercialize a novel therapy for glioblastoma for our cancer center. I am on the Board of Directors and it has intellectual property developed by our cancer center.; I have several patents with colleagues involving novel biomarkers for cancer and two devices for sexual dysfunction and urinary incontinence. No revenues at this time and our University IP office is working with industry to determine if these can be comme
 
Andrew Wagner
No Relationships to Disclose
 
Yingye Zheng
No Relationships to Disclose
 
Daniel W. Lin
Consulting or Advisory Role - Astellas Pharma; Bayer; Myriad Genetics
Research Funding - GenomeDx (Inst); Genomic Health (Inst)